Photodynamic therapy: Applications in bladder cancer and other malignancies

Journal of the Formosan Medical Association

Volumn 96, Issue 11, 1997, Pages 853-856

  Chang, Shi Chung ^a,b   Bown, Stephen G ^b  

^a BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

5 aminolevulinic acid; Dihematoporphyrin ether ester; Oncology; Photodynamic therapy; Photosensitizer

Indexed keywords

AMINOLEVULINIC ACID; PHOTOFRIN; PHOTOFRIN II; PHOTOSENSITIZING AGENT;

ARTICLE; BLADDER CANCER; BRAIN TUMOR; CANCER PREVENTION; ESOPHAGUS CANCER; GYNECOLOGIC CANCER; HEAD AND NECK CANCER; LUNG CANCER; PHOTODYNAMIC THERAPY; PHOTOSENSITIZATION; PROSTATE CANCER; RECURRENT CANCER; SKIN CANCER; STOMACH CANCER;

EID: 0031405018     PISSN: 09296646     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (118)

1. Smetana Z, Mendelson E, Manor J, et al: Photodynamic inactivation of herpes viruses with phthalocyanine derivatives J Photoehem Photobiol B 1994;22:37-43.
2. Malik Z, Hanania J, Nitzan Y: Bactericidal effects of photoactivated porphvrins-an alternative approach to antimicrobial drugs. J Photochem Photobiol B 1990; 5:281-93.
3. Kelly JF, Snell ME: Hematoporphyrin derivative: a possible aid in the diagnosis and therapy of carcinoma of the bladder. J Urol 1976;115:150-1.
4. Pettier RH, Chow WA, LaPlante JP, et al: Non-invasive technique for obtaining fluorescence excitation and emission spectra in vivo. Photochem Photobiol 1986;44:679-87.
5. Spring KR, Smith PD: Illumination and detection systems for quantitative fluorescence microscopy. J Microsc 1987; 10:265-78.
6. Gray JW, Pinkel D, Brown JM: Fluorescence in situ hybridization in cancer and radiation biology. Radiat Res 1994;137:275-89.
7. Tsuchiya A, Obara N, Miwa M, et al: Hematoporphyrin derivative and laser photoradiation in the diagnosis and treatment of bladder cancer. J Urol 1983;130: 79-82.
8. Hisazumi H, Misaki T, Miyoshi N: Photoradiation therapy of bladder tumors. J Urol 1983;130:685-7.
9. Benson RC Jr, Kinsey JH, Cortese DA, et al: Treatment of transitional cell carcinoma of the bladder with hematoporphyrin derivative phototherapy. J Urol 1983; 130:1090-5.
10. Prout GR Jr, Lin CW, Benson RC Jr, et al: Photodynamic therapy with hematoporphyrin derivative in the treatment of superficial transitional-cell carcinoma of the bladder. N Engl J Med 1987;317:1251-5.
11. Hisazumi H, Miyoshi N, Naito K, et al: Whole bladder wall photoradiation therapy for carcinoma in situ of the bladder: a preliminary report. J Urol 1984;131:884-7.
12. Benson RC Jr: Treatment of diffuse transitional cell carcinoma in situ by whole bladder hematoporphyrin derivative photodynamic therapy. J Urol 1985;134:675-8.
13. Benson RC Jr: Integral photoradiation therapy of multifocal bladder tumors. Eur Urol 1986;12:47-53.
14. Nseyo UO, Dougherty TJ, Sullivan L: Photodynamic therapy in the management of resistant lower urinary tract carcinoma. Cancer 1987;60:3113-9.
15. Nseyo UO: Photodynamic therapy. Urol Clin North Am 1992;19:591-9.
16. Shumaker BP, Hetzel FW: Clinical laser photodynamic therapy in the treatment of bladder carcinoma. Photochem Photobiol 1987;46:899-901.
17. Naito K, Hisazumi H, Uchibayashi T, et al: Integral laser photodynamic treatment of refractory multifocal bladder tumors. J Urol 1991;146:1541-5.
18. Uchibayashi T, Koshida K, Kunimi K, et al: Whole bladder wall photodynamic therapy for refractory carcinoma in situ of the bladder. Br J Cancer 1995;71:625-8.
19. D'Hallewin MA, Baert L: Long-term results of whole bladder wall photodynamic therapy for carcinoma in situ of the bladder. Urology 1995;45:763-7.
20. Kriegmair M, Waidelich R, Lumper W, et al: Integral photodynamic treatment of refractory superficial bladder cancer. J Urol 1995;154:1339-41.
21. Windahl T, Lofgren LA: Two years' experience with photodynamic therapy of bladder carcinoma. Br J Urol 1993;71:187-91.
22. Kriegmair M, Baumgartner R, Lumper R, et al: Early-clinical experience with 5-aminolevulinic acid for the photodynamic therapy of superficial bladder cancer. Br J Urol 1996;77:667-71.
23. Marcus SL, Dugan MH: Global status of clinical photodynamic therapy. Lasers Surg Med 1992;12:318-24.
24. Harty JI, Amin M, Wieman TJ, et al: Complications of whole bladder dihematoporphyrin ether photodynamic therapy. J Urol 1989;141:1341-6.
25. Windahl T, Andersson SO, Lofgren LA: Photodynamic therapy of localised prostatic cancer. Lancet 1990;336:1139.
26. Pantelides ML, Whitehurst C, Moore JV, et al: Photodynamic therapy for localised prostatic cancer: light penetration in the human prostate gland. J Urol 1990; 143:398-401.
27. Pantelides ML, Moore JV, Forbes E, et al: The uptake of porphyrin and zinc-metalloporphyrin by the primate prostate. Photochem Photobiol 1993;57:838-41.
28. Whitehurst C, Pantelides ML, Moore JV, et al: In vivo to post-mortem change in tissue penetration of red light. Lasers Med Sci 1989;5:395-8.
29. Whitehurst C, Pantelides ML, Moore JV, et al: Optimization of multifiber light delivery for the photodynamic therapy of localized prostate cancer. Photochem Photobiol 1993;58:589-93.
30. Whitehurst C, Pantelides ML, Moore JV, et al: In vivo laser light distribution in human prostatic carcinoma. J Urol 1994;151:1411-5.
31. Lee LK, Whitehurst C, Pantelides ML, et al: In situ comparison of 665 nm and 633 nm wavelength light penetration in the human prostate gland. Photochem Photobiol 1995;62:882-6.
32. Selman SH, Keck RW: The effect of transurethral light on the canine prostate after sensitization with the photosensitizer tin(II) etiopurpurin dichloride: a pilot study. J Urol 1994;152:2129-32.
33. Chang SC, Buonaccorsi G, MacRobert AJ, et al: Interstitial and transurethral photodynamic therapy of the canine prostate with meso-tetra-(m-hydroxyphenyl) chlorin. Int J Cancer 1996;67:555-62.
34. Chang SC, Buonaccorsi G, MacRobert AJ, et al: Interstitial photodynamic therapy in the canine prostate with disulfonated aluminum phthalocyanine and 5-aminolevulinic acid induced protoporphyrin IX. Prostate 1997;32:89-98.
35. Wise BL, Taxdal DR. Studies of the blood-brain barrier utilizing hematoporphyrin: short communication. Brain Res 1967;4:387-9.
36. Perria C, Delitala G, Francaviglia N, et al: The uptake of hematoporphyrin derivative by cells of human glioma: determination by fluorescence microscopy. Int Royal College Surgeons Med Sci 1983;11:46-7.
37. Laws ER Jr., Cortese DA, Kinsey: Photoradiation therapy in the treatment of malignant brain tumors: a phase I (feasibility) study. Neurosurgery 1981;9:672-8.
38. Muller PJ, Wilson BC: Photodynamic therapy: cavitary photoillumination of malignant cerebral tumours using a laser coupled inflatable balloon. Can J Neurol Sci 1985;12:371-3.
39. Muller PJ, Wilson BC: Photodynamic therapy of primary malignant brain tumours: clinical effects, postoperative ICP and light penetration of the brain. Photochem Photobiol 1987;46:929-35.
40. Kaye AH, Morstyn G, Brownbill D: Adjuvant high-dose photoradiation therapy in the treatment of cerebral glioma: a phase I-II study. J Neurosurg 1987;67:500-5.
41. Kostron H, Weiser G, Fritsch E, et al: Photodynamic therapy of malignant brain tumors: clinical and neuropathological results. Photochem Photobiol 1987;46:937-43.
42. Perria C, Carai M, Falzai A, et al: Photodynamic therapy of malignant brain tumors: clinical results of, difficulties with, questions about, future prospects for the neurological applications. Neurosurgery 1988;23:557-63.
43. Muller PJ, Wilson BC: Photodynamic therapy of malignant brain tumors. Lasers Med Sci 1990;5:245-51.
44. Powers SK, Cush SS, Walstad DL, et al: Stereotactic intratumoral photodynamic therapy for recurrent malignant brain tumors. Neurosurgery 1991;29:688-96.
45. Kostron H, Hochleitner BW, Obwegeser A: Clinical and experimental results of photodynamic therapy in neurosurgery. In: Proceedings of the 5th International Photodynamic Association Biennial Meeting, 1994, Florida. Society of Photo-optical Instrumentation Engineers 1995;2371:126-8.
46. Hayata Y, Kato H, Konaka C, et al: Hematoporphyrin derivative and laser photoradiation in the treatment of lung cancer. Chest 1982;81:269-77.
47. Cortese DA, Kinsey JH: Hematoporphyrin derivative phototherapy for local treatment of cancer of the tracheobronchial tree. Ann Otol Rhinol Laryngol 1982;91:652-5.
48. Balchum OJ, Doiron DR: Photoradiation therapy of endobronchial lung cancer: large obstructing tumors, non-obstructing tumors, and early-stage bronchial cancer lesions. Clin Chest Med 1985;6:255-75.
49. Lam SN, Muller L, Miller RR, et al: Predicting the response of obstructive endobronchial tumors to photodynamic therapy. Cancer 1986;58:2298-306.
50. Kato H, Konaka C, Ono J, et al: Effectiveness of HpD and radiation therapy in lung cancer. In: Kessel D, Dougherty TJ, eds. Methods in Porphyrin Photosensitization. New York: Plenum Press, 1983:23-39.
51. Hayata Y, Kato H, Konaka C, et al: Photoradiation therapy with hematoporphyrin derivative in early and stage 1 lung cancer. Chest 1984;86:169-77.
52. Edell ES, Cortese DA: Bronchogenic phototherapy with hematoporphyrin derivative for treatment of localized bronchologenic carcinoma: a 5-year experience. Mayo Clin Proc 1987;62:8-14.
53. Karanov S, Kostadinov D, Shopova M, et al: Photodynamic therapy in lung and gastrointestinal cancer. J Photochem Photobiol B 1990;6:175-81.
54. Furuse K, Fukuoka M, Kato H, et al: A prospective phase II study on photodynamic therapy with photofrin II for centrally located early-stage lung cancer: the Japan Lung Cancer Photodynamic Study Group. J Clin Oncol 1993;11:1852-7.
55. Okunaka T, Kato H: Laser bronchoscopic therapy of lung cancer. Gan-To-Kagaku-Ryoho 1995;22:179-84. [in Japanese, English abstract]
56. Dugan M, Marcus S, Parker K, et al: Retrospective study of 170 patients treated with photodynamic therapy for endobronchial malignancies. Lasers Surg Med 1989; 9:38-45.
57. McCaughan JS Jr, Williams TE Jr, Bethel BH: Photodynamic therapy of endobronchial tumors. Lasers Surg Med 1986;6:336-45.
58. Hugh-Jones P, Gardner WN: Laser photodynamic therapy for inoperable bronchogenic squamous carcinoma. QJ Med 1987;64:565-82.
59. Kato H, Konaka C, Kawate N, et al: Five-year disease-free survival of a lung cancer patient treated only by photodynamic therapy. Chest 1986;90:768-70.
60. NelsonJS, Fairshter RD, Berns MW: Long-term survival of a lung cancer patient treated with photodynamic therapy. Lasers Surg Med 1990;10:208-10.
61. Imamura S, Kusunoki Y, Takifuji N, et al: Photodynamic therapy and/or external beam radiation therapy for roentgenologically occult lung cancer. Cancer 1994; 73:1608-14.
62. Kato H, Cortese DA: Early detection of lung cancer by means of hematoporphyrin derivative fluorescence and laser photoradiation. Clin Chest Med 1985;6:237-53.
63. Edell ES, Cortese DA: Detection and phototherapy of lung cancer. In: Morstyn G, Kaye A, eds. Phototherapy of Cancer. London: Harwood, 1990:185-91.
64. Lam S, Palcic B, McLean D, et al: Detection of early lung cancer using low dose Photofrin II. Chest 1990; 97:333-7.
65. Baumgartner R, Fisslinger H, Jocham D, et al: A fluorescence imaging device for endoscopic detection of early stage cancer: instrumental and experimental studies. Photochem Photobiol 1987;46:759-63.
66. Kato H, Konaka C, Ono J, et al: Preoperative laser photo-dynamic therapy in combination with operation in lung cancer. J Thorac Cardiovasc Surg 1985; 90:420-9.
67. LoCicero J, Metzdorff M, Almgren C: Photodynamic therapv in the palliation of late-stage obstructing non-small-cell lung cancer. Chest 1990;98.97-100.
68. Moghissi K, Parsons RJ, Dixon K: Photodynamic therapy (PDT) for bronchial carcinoma with the use of rigid bronchoscope. Lasers Med Sci 1992;7:381-5.
69. Lam S: Photodynamic therapy of lung cancer. Semin Oncol 1994;21:15-9.
70. Corti L, Maluta S, Tomio L, et al: Photodynamic therapy in gynecological cancer. Lasers Med Sci 1989;4:155-8.
71. Lele SB, Piver MS, Mang TS, et al: Photodynamic therapy in gynecologic malignancies. Gynecol Oncol 1989;34.350-2.
72. Muroya T, Suehiro Y, Umayahara K, et al: Photodynamic therapy (PDT) for early cervical cancer. Gan-To-Kagaku-Ryoho 1996;23:47-56. [in Japanese, English abstract]
73. Schuller DE, McCaughan JS, Rock RP: Photodynamic therapy in head and neck cancer. Arch Otolaryngol 1985;111:351-5.
74. Zhao FY, Zhang KH, Ma DQ, et al: Treatment of 510 cases of oral squamous cell carcinoma. Ann Acad Med Singapore 1989;18:533-6.
75. Schweitzer VG: Photodynamic therapy for treatment of head and neck cancer. Otolaryngol Head Neck Surg 1990;102:225-32.
76. Grossweiner LI, Hill JH, Lobraico RV: Photodynamic therapy of head and neck squamous cell carcinoma: optical dosimetry and clinical trial. Photochem Photobiol 1987;46:911-7.
77. Keller GS, Doiron DR, Fisher GU: Photodynamic therapy in otolaryngology-head and necksurgery. Arch Otolaryngol 1985;111:758-61.
78. Feyh J, Goetz A, Muller W, et al: Photodynamic therapy in head and neck surgery. J Photochem Photobiol B 1990; 7:353-8.
79. Gluckman JL: Hematoporphyrin photodynamic therapy: is there truly a future in head and neck oncologv? Reflections on a 5-year experience. Laryngoscope 1991; 101:36-42.
80. Zhao FY, Zhang KH, Jiang F, et al: Use of photodynamic therapv in the treatment of oral and maxillofacial cancer and precancer: report of 104 cases and preliminary observation on the mechanism. Lasers Med Sci 1987;4:117-22.
81. Yoshida T, Saeki T, Ohashi S, et al: Clinical study of photodynamic therapy for laryngeal cancer. Nippon Jibunkoka Gakkai Kaiho 1995;98:795-804. [in Japanese, English abstract]
82. Lebovics RS, DeLaney TF: Sensitizers of photoradiation and ionizing radiation in the management of head and neck cancer. Med Clin North Am 1993;77:583-96.
83. DeMaster TR, Stein HJ: Surgical therapy for cancer of esophagus and cardia. In: Castell DO, ed. The Esophagus. Boston: Little Brown, 1992:299-342.
84. Tian ME, Qui SL, Ji Q: Preliminary results of hematoporphyrin derivative-laser treatment for 13 cases of earh esophageal carcinoma. Adv Exp Med Biol 1985; 193:21-5.
85. Calzavara F, Tomio L, Corti L, et al: Oesophageal cancer treated by photodynamic therapy alone or followed by radiation therapy. J Photochem Photobiol 1990;6:167-74.
86. Sibille A, Lambert R, Souquet JC, et al: Long-term survival after photodynamic therapy for esophageal cancer. Gastroenterology 1995;108:337-44.
87. Overholt BF, Panjehpour M: Photodynamic therapy in Barrett's esophagus: reduction of specialized mucosa, ablation of dysplasia, and treatment of superficial esophageal cancer. Semin Surg Oncol 1995:11:372-6
88. McCaughan JS Jr, Nims TA, Guy JT, et al: Photodynamic therapy for esophageal tumors. Arch Surg 1989;124: 74-80.
89. Segalin A, Little A, Ruol A, et al: Surgical and endoscopic palliation of esophageal carcinoma. Ann Thorac Surg 1989; 48:267-71.
90. Likier HM, Levine JG, Lightdale C: Photodynamic therapy for completely obstructing esophageal carcinoma. Gastrointest Endosc 1991;37:75-8.
91. Marcon NE: Photodynamic therapy and cancer of the esophagus. Semin Oncol 1994;21:20-3.
92. Heier SK, Rothman KA, Heier LM, et al: Photodvnamic therapy for obstructing esophageal cancer: light dosimetry and randomized comparison with Nd:YAG laser therapv. Gastroenterology 1995;109:63-72.
93. Brown S: PDT comes of age [Editorial]. Int Photodyn 1996;1:1.
94. Hayata Y, Kato H, Konaka C, et al: Overview of clinical PDT. In: Spinelli P, Dal Fante M, Marchesini R, eds. Photodynamic Therapy and Biomedical Lasers, Amsterdam: Elsevier Science, 1992:1-5.
95. Kato H, Kato T, Furuse K, et al: Photodynamic therapy in the early treatment of cancer. Gan-To-Kagaku-Ryoho 1990; 17:1833-8. [in Japanese, English abstract]
96. Mimura S, Ichii M, Okuda S: Photodynamic therapy for early gastric cancer using excimer dye laser. In: Spinelli P, Dal Fante M, Marchesini R, eds. Photodynamic Therapy and Biomedical Lasers, Amsterdam. Elsevier Science, 1992:272-6.
97. Mimura S, Narahara H, Otani T, et al. Photodynamic therapy for early gastric cancer: its application for wider lesions. In: Proceedings of the 5th International Photodynamic Association Biennial Meeting, 1994, Florida. SPIE 1994;2371:522-5.
98. Mimura S, Ichii M, Imanish K, et al: Indications for and limitations of HpD photodynamic therapy for esophageal cancer and gastric cancer. Gan-To-Kagaku-Ryoho 1988; 15:1440-4. [in Japanese, English abstract]
99. Ito Y, Kasugai T: Use of endoscopic laser in gastro-enterology. Ann Acad Med Singapore 1987;16:290-3.
100. Dougherty TJ: Photoradiation therapy for cutaneous and subcutaneous malignancies. J Invest Dermatol 1981;77:122-4.
101. Keller GS, Razum NJ, Doiron DR: Photodynamic therapy for nonmelanoma skin cancer. Facial Plast Surg 1989; 6:180-4.
102. Pennington DG, Waner M, Knox A: Photodynamic therapy for multiple skin cancers Plast Reconstr Surg 1988;82:1067-71.
103. Buchannan RB, Carruth JAS, McKenzie AL, et al: Photodynamic therapy in the treatment of malignant tumours of the skin and head and neck. Eur J Surg Oncol 1989;15:400-6.
104. Wilson BD, Mang TS, Cooper RN, et al: Use of photodynamic therapy for the treatment of extensive basal cell carcinomas. Facial Plast Surg 1989;6:185-9.
105. Jones CM, Mang T, Cooper RN, et al: Photodynamic therapy in the treatment of Bowen's disease. J Am Acad Dermatol 1992;27:979-82.
106. Waldow SM, Lobraico RV, Kohler IK, et al: Photodynamic therapy for treatment of malignant cutaneous lesions. Lasers Surg Med 1987;7:451-6.
107. Robinson PJ, Carruth JAS, Fairris GM: Photodynamic therapy: a better treatment for widespread Bowen's disease. Br J Dermatol 1988;119:59-61.
108. Petrelli NJ, Cebollero JA, Rodriguez-Bigas M, et al: Photodynamic therapy in the management of neoplasms of the perianal skin. Arch Surg 1992;127: 1436-8.
109. Kennedy JC. Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present-clinical experience. J Photochem Photobiol B 1990;6: 143-8.
110. Cairnduff F, Stringer MR, Hudson EJ, et al: Superficial photodynamic therapy with topical 5-aminolaevulinic acid for superficial primary and secondary skin cancer. Br J Cancer 1994;69:605-8.
111. Wolf P, Rieger E, Kerl H: Topical photodynamic therapy with endogenous porphyrins after application of 5-aminolevulinic acid. J Am Acad Dermatol 1993;28:17-21.
112. Svanberg K, Andersson T, Killander D, et al: Photodynamic therapy of non-melanoma malignant tumours of the skin using topical 5-amino levulinic acid sensitization and laser irradiation. Br J Dermatol 1994;130:743-51.
113. Fijan S, Honigsmann H, Ortel B: Photodynamic therapy of epithelial skin tumours using delta-aminolaevulinic acid and desferrioxamine. Br J Dermatol 1995;133:282-8.
114. Warloe T, Peng Q, Heyerdahl H, et al: Photodynamic therapy with 5-aminolevulinic acid induced porphyrins and DMSO/EDTA for basal cell carcinoma. In: Proceedings of the 5th International Photodynamic Association Biennial Meeting, 1994, Florida. SPIE 1995;2371:226-35.
115. Robert DJH, Cairnduff F: Photodynamic therapy of primary skin cancer: a review. Br J Plast Surg 1995; 48:360-70.
116. Chang SC, MacRobert AJ, Bown SG: Biodistribution of protoporphyrin IX in rat urinary bladder after intravesical instillation of 5-aminolevulinic acid. J Urol 1996;155:1744-8.
117. Chang SC, MacRobert AJ, Bown SG: Photodynamic therapy of rat urinary bladder with intravesical instillation of 5-aminolevulinic acid: light diffusion medium and histological changes. J Urol 1996; 155:1749-53.
118. Szeimies RM, Abels C, Tritsch C, et al: Wavelength-dependent in vitro and in vivo photodynamic effects after sensitization with 5-aminolevulinic acid induced protoporphyrin IX. In: Proceedings of the European Optical Society, 1995, Barcelona. SPIE 1995; 2625:44-7.